News center

Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences

Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs

Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA

Les Echos features Owkin as a key AI partner for pharma

Owkin-Identified Biomarker-Defined Patient Subgroups In Phase 2 Trial Data Will Be Retrospectively Assessed By Servier

Owkin announces international validation results of BRCAura: AI-driven screening for gBRCA mutations directly from pathology slides

Université Paris-Saclay and Owkin: a unique alliance to propel university medical research to the top of the European rankings through AI

L'Opinion features Owkin about Franco-German initiative in AI-powered oncology

France 24 interviews Owkin's CEO Thomas Clozel about Biomedical Agentic AI

Owkin unveils Europe’s first pan-European agentic infrastructure for biology at the Franco-German Digital Sovereignty Summit

Owkin announces availability of K Pro in the AWS Marketplace SaaS category

Owkin Launches K Pro: the First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models